SCARPA, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 2.728
AS - Asia 1.726
EU - Europa 954
AF - Africa 251
SA - Sud America 221
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 13
Totale 5.924
Nazione #
US - Stati Uniti d'America 2.562
SG - Singapore 548
VN - Vietnam 298
CN - Cina 276
IT - Italia 274
HK - Hong Kong 180
BR - Brasile 130
DE - Germania 95
FI - Finlandia 94
GB - Regno Unito 58
PL - Polonia 58
IN - India 50
FR - Francia 46
SE - Svezia 36
CA - Canada 35
NL - Olanda 31
RU - Federazione Russa 31
BD - Bangladesh 30
JP - Giappone 28
IQ - Iraq 26
PH - Filippine 26
TR - Turchia 24
ES - Italia 20
MX - Messico 17
NP - Nepal 17
ZA - Sudafrica 17
AR - Argentina 16
AT - Austria 16
PK - Pakistan 16
SA - Arabia Saudita 16
UZ - Uzbekistan 14
IE - Irlanda 13
UA - Ucraina 13
VE - Venezuela 13
BJ - Benin 12
CZ - Repubblica Ceca 12
EC - Ecuador 12
ID - Indonesia 12
RO - Romania 12
BB - Barbados 11
CO - Colombia 11
GT - Guatemala 11
KR - Corea 11
ME - Montenegro 11
PS - Palestinian Territory 11
BA - Bosnia-Erzegovina 10
BY - Bielorussia 10
CG - Congo 10
KG - Kirghizistan 10
MA - Marocco 10
PY - Paraguay 10
AU - Australia 9
AZ - Azerbaigian 9
CI - Costa d'Avorio 9
JM - Giamaica 9
KE - Kenya 9
PR - Porto Rico 9
RW - Ruanda 9
ZW - Zimbabwe 9
AL - Albania 8
BE - Belgio 8
CL - Cile 8
ET - Etiopia 8
IR - Iran 8
LB - Libano 8
MD - Moldavia 8
MK - Macedonia 8
ML - Mali 8
MY - Malesia 8
NC - Nuova Caledonia 8
PA - Panama 8
TZ - Tanzania 8
CV - Capo Verde 7
CY - Cipro 7
DJ - Gibuti 7
DK - Danimarca 7
EG - Egitto 7
HU - Ungheria 7
IL - Israele 7
LC - Santa Lucia 7
MR - Mauritania 7
NG - Nigeria 7
PE - Perù 7
TJ - Tagikistan 7
TN - Tunisia 7
TT - Trinidad e Tobago 7
XK - ???statistics.table.value.countryCode.XK??? 7
AM - Armenia 6
AO - Angola 6
BW - Botswana 6
CM - Camerun 6
CR - Costa Rica 6
CU - Cuba 6
CW - ???statistics.table.value.countryCode.CW??? 6
DZ - Algeria 6
GA - Gabon 6
GH - Ghana 6
GR - Grecia 6
HN - Honduras 6
JO - Giordania 6
Totale 5.669
Città #
Ashburn 423
Singapore 333
Fairfield 288
San Jose 282
Chandler 179
Hong Kong 164
Houston 126
Woodbridge 115
Cambridge 106
Seattle 94
Ho Chi Minh City 87
Wilmington 70
Helsinki 69
Hanoi 66
Los Angeles 64
Santa Clara 63
Beijing 54
Padova 54
Ann Arbor 50
Bytom 37
San Diego 37
Munich 36
Boardman 33
New York 30
Medford 26
Princeton 26
Council Bluffs 25
Lauterbourg 22
Tokyo 22
Des Moines 21
London 20
Da Nang 19
Milan 19
Montreal 18
Baghdad 15
Dong Ket 15
Haiphong 15
Roxbury 15
Orem 14
Buffalo 13
The Dalles 13
Turku 13
Chicago 12
Cotonou 12
Dallas 12
São Paulo 12
Warsaw 12
Bridgetown 11
Chennai 11
Phoenix 11
Tashkent 11
Poplar 10
Abidjan 9
Denver 9
Guangzhou 9
Harare 9
Johannesburg 9
Kigali 9
Vienna 9
Addis Ababa 8
Ankara 8
Baku 8
Bamako 8
Bologna 8
Charlotte 8
Dublin 8
Frankfurt am Main 8
Lappeenranta 8
Noumea 8
Nuremberg 8
Panama City 8
Redondo Beach 8
Stockholm 8
Toronto 8
Dushanbe 7
Minsk 7
Podgorica 7
Amman 6
Antananarivo 6
Athens 6
Bishkek 6
Castries 6
Crevacuore 6
Havana 6
Hefei 6
Hải Dương 6
Jeddah 6
Kathmandu 6
Lima 6
Managua 6
Manchester 6
Nairobi 6
Naples 6
Nouakchott 6
Padua 6
Shenzhen 6
Tirana 6
Ulan Bator 6
Willemstad 6
Accra 5
Totale 3.646
Nome #
Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency (CVID): A Multicenter Retrospective Study of Patients From Italian PID Referral Centers 345
Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies 314
THE NATURAL HISTORY OF AUTOIMMUNE ADDISON'S DISEASE FROM THE DETECTION OF AUTOANTIBODIES TO DEVELOPMENT OF THE DISEASE: A LONG FOLLOW-UP STUDY ON 143 PATIENTS 307
Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients 298
Tryptophan hydroxylase autoantibodies as markers of a distinct autoimmune gastrointestinal component of autoimmune polyendocrine syndrome type 1. 269
Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives 268
L-Arginine prevents inflammatory and pro-calcific differentiation of interstitial aortic valve cells 264
Venom immunotherapy during COVID-19 pandemic: Experience from a University Allergy Center in Northern Italy 258
Addison's disease: a survey on 633 patients in Padova. 244
Rituximab in refractory sarcoidosis: a single centre experience 222
Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype 222
Immunology of sarcoidosis: old companions, new relationships 221
Appropriate lung management in patients with primary antibody deficiencies 220
AT1AA (Angiotensin II Type-1 Receptor Autoantibodies): Cause or Consequence of Human Primary Aldosteronism? 220
A bone-based 3D scaffold as an in-vitro model of microenvironment–DLBCL lymphoma cell interaction 219
Clinical outcome, incidence and SARS-CoV-2 infection fatality rates in Italian patients with Inborn Errors of Immunity 206
The broad spectrum of lung diseases in primary antibody deficiencies 199
Vaccination in pads 191
Addison's disease: A survey on 633 patients in Padova 178
Impact of Hypogammaglobulinemia on the Course of COVID-19 in a Non-Intensive Care Setting: A Single-Center Retrospective Cohort Study 172
The natural history of autoimmune Addison's disease with a non-classical presentation: A case report and review of literature 171
Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic 169
Subcutaneous ig replacement therapy in primary and secondary hypogammaglobulinemia: A retrospective single centre study of 203 patients 167
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) 158
Mortality in Severe Antibody Deficiencies Patients during the First Two Years of the COVID-19 Pandemic: Vaccination and Monoclonal Antibodies Efficacy 146
GSK-3 Inhibition Modulates Metalloproteases in a Model of Lung Inflammation and Fibrosis 123
Disease specificity of anti-tryptophan hydroxylase-1 and anti-AIE-75 autoantibodies in APECED and IPEX syndrome 115
Altered B cell homeostasis and Toll-like receptor 9-driven response in patients affected by autoimmune polyglandular syndrome Type 1: Altered B cell phenotype and dysregulation of the B cell function in APECED patients 107
Totale 5.993
Categoria #
all - tutte 17.624
article - articoli 17.624
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.248


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021224 0 0 0 0 0 0 0 0 0 0 99 125
2021/2022471 6 34 98 19 47 29 9 48 38 10 38 95
2022/2023320 57 44 16 48 46 31 11 25 27 0 13 2
2023/2024190 5 19 28 17 15 32 15 7 5 8 16 23
2024/2025828 5 50 44 39 91 31 40 89 65 34 122 218
2025/20263.336 180 200 384 483 326 178 661 270 322 200 132 0
Totale 5.993